secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001193125-25-142093
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics cuts Series B warrant shares from 1.26B to 35.5M; cancels Series A warrants
--------------------------------------------------------------------------------

- Cancelled all Series A warrants exercisable for up to 280M shares of common stock.
- Series B warrants amended to reduce total shares issuable from ~1.26B to ~35.5M; cashless exercise ratio cut from 3:1 to 1:1.
- Investors agreed to return ~12.2M Private Placement Shares and Pre-Funded Warrants in exchange for 115% repayment from future capital raises.
- Registration Rights Agreement terminated; restrictions on subsequent equity sales waived.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525142093/0001193125-25-142093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525142093/d942989d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-142093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer